Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, View ORCID ProfileSander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Koenig, Thor Ueland, Ola Kleveland, Pal Aukrust, Lars Gullestad, View ORCID ProfileJürgen Bernhagen, Gerard Pasterkamp, View ORCID ProfileAnnette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis
doi: https://doi.org/10.1101/2023.03.24.23287543
Savvina Prapiadou
1University of Patras School of Medicine, Patras, Greece
2Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
3Broad Institute of MIT and Harvard, Cambridge, MA, USA
Luka Živković
4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
Barbara Thorand
5Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
PhDMarc J. George
6Department of Clinical Pharmacology, Division of Medicine, University College London, London, United Kingdom
MB, ChB, PhDSander W. van der Laan
7Central Diagnostics Laboratory, Division Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
PhDRainer Malik
4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
PhDChristian Herder
8German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany
9Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany
10Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich Heine University, Düsseldorf, Germany
PhDWolfgang Koenig
11German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
12Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
13German Heart Center Munich, Technical University of Munich, Munich, Germany
MDThor Ueland
14Thrombosis Research Center (TREC), Division of internal medicine, University hospital of North Norway, Tromsø, Norway
15Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
16Institute of Clinical Medicine, University of Oslo, Oslo, Norway
PhDOla Kleveland
17Clinic of Cardiology, St Olavs Hospital, Trondheim, Norway
18Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
MD, PhDPal Aukrust
15Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway
16Institute of Clinical Medicine, University of Oslo, Oslo, Norway
19Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
MD, PhDLars Gullestad
20Department of Cardiology Oslo University Hospital Rikshospitalet, Oslo, Norway
MD, PhDJürgen Bernhagen
4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
11German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
21Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
PhDGerard Pasterkamp
7Central Diagnostics Laboratory, Division Laboratories, Pharmacy, and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands
MDAnnette Peters
5Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany
22Chair of Epidemiology, Institute for Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians-University Munich, Munich, Germany
23Munich Heart Alliance, German Center for Cardiovascular Health (DZHK e.V., partner-site Munich), Munich, Germany
PhDAroon D. Hingorani
6Department of Clinical Pharmacology, Division of Medicine, University College London, London, United Kingdom
24Centre for Translational Genomics, Institute of Cardiovascular Science, University College London, London, United Kingdom
MB, BS, PhDJonathan Rosand
2Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
3Broad Institute of MIT and Harvard, Cambridge, MA, USA
25Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
MDMartin Dichgans
4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
11German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
19Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway
26German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
MDChristopher D. Anderson
2Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
3Broad Institute of MIT and Harvard, Cambridge, MA, USA
27Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
MD, MMScMarios K. Georgakis
3Broad Institute of MIT and Harvard, Cambridge, MA, USA
4Institute for Stroke and Dementia Research, Ludwig-Maximilians-University of Munich, Munich, Germany
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted March 28, 2023.
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, Sander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Koenig, Thor Ueland, Ola Kleveland, Pal Aukrust, Lars Gullestad, Jürgen Bernhagen, Gerard Pasterkamp, Annette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis
medRxiv 2023.03.24.23287543; doi: https://doi.org/10.1101/2023.03.24.23287543
Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis
Savvina Prapiadou, Luka Živković, Barbara Thorand, Marc J. George, Sander W. van der Laan, Rainer Malik, Christian Herder, Wolfgang Koenig, Thor Ueland, Ola Kleveland, Pal Aukrust, Lars Gullestad, Jürgen Bernhagen, Gerard Pasterkamp, Annette Peters, Aroon D. Hingorani, Jonathan Rosand, Martin Dichgans, Christopher D. Anderson, Marios K. Georgakis
medRxiv 2023.03.24.23287543; doi: https://doi.org/10.1101/2023.03.24.23287543
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3042)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4773)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1096)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4545)
- Nursing (242)
- Nutrition (671)
- Oncology (2365)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7136)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (505)
- Toxicology (63)
- Transplantation (218)
- Urology (187)